Terflavoxate
CAS No. 86433-40-1
Terflavoxate( —— )
Catalog No. M36117 CAS No. 86433-40-1
Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 199 | In Stock |
|
| 5MG | 174 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTerflavoxate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTerflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
-
DescriptionTerflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMicrotubule Associated
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86433-40-1
-
Formula Weight419.51
-
Molecular FormulaC26H29NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OC(CN1CCCCC1)(C)C)(=O)C2=C3C(C(=O)C(C)=C(O3)C4=CC=CC=C4)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
L-2-Phosphoglyceric ...
2-Phosphoglyceric acid (2PGA) is a glyceric acid which serves as the substrate in the ninth step of glycolysis. It is catalyzed by enolase into phosphoenolpyruvate (PEP) the penultimate step in the conversion of glucose to pyruvate.
-
Substance P (1-7)(TF...
Substance P (1-7)(TFA) is a fragment of the neuropeptide, substance P (SP).
-
β- Amyloid (16-23)
β- Amyloid (16-23)
Cart
sales@molnova.com